Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Graft vs Host Disease 1Cytopenia 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 21fludarabine phosphate 18Whole-Body Irradiation 17Melphalan 15fludarabine 14Tacrolimus 14Busulfan 12Mycophenolic Acid 11Peripheral Blood Stem Cell Transplantation 10Alemtuzumab 8Methotrexate 5Cyclosporine 5Antilymphocyte Serum 5thymoglobulin 3Thiotepa 3Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3sargramostim 2Transplantation 2Sirolimus 2Rituximab 2Methylprednisolone 2Mesna 2Influenza Vaccines 2Immunoenzyme Techniques 2Hematopoietic Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2Etoposide 2Cord Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anemia, Aplastic × Emapalumab × Clear all
NCT06430788 2025-12-17

A Study of Emapalumab for Pediatric Aplastic Anemia

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
35 enrolled
Classical hematology

Bone Marrow Failure Disorders, Cytopenia, Anemia, Aplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡